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Laboratory analysis of extravascular 
specimens and body fluids
Ana-Maria Simundic
Department of Medical Laboratory diagnostics, Clinical Hospital 
“Sveti Duh”, Zagreb, Croatia
While whole blood, serum and plasma are exten-
sively studied sample types which are commonly 
used in laboratories worldwide, some other matri-
ces like various body fluids, are not so well known 
and are only recently increasingly gaining impor-
tance. The reason behind this are international 
quality standards and accrediting bodies which 
now clearly require that some specific quality 
characteristics are tested and known for each 
unique sample type: precision, accuracy, linearity, 
measurement range, sample collection, sample 
stability, interferences, reporting, clinical utility 
and some other. These requirements and quality 
specifications have raised many issues and chal-
lenges for laboratories. Therefore, the aim of this 
symposium is to provide an overview of the cur-
rent knowledge and understanding of the sample 
characteristics, analytical specificities and clinical 
utility of samples such as pleural, peritoneal and 
synovial fluid as well as urine. Some new emerging 
protein biomarkers and analytical techniques such 
as microchip technology, proteomic and lipidomic 
analysis, gas chromatography and mass spectrom-
etry and molecular techniques will also be dis-
cussed. 
We hope that this symposium will address some 
frequently raised questions and provide useful 
guidance for professionals in laboratory medicine 
as well as other professions in the healthcare.
Corresponding author: amsimundic@kbsd.hr 
Paracentesis - aspiration of ascitic 
fluid from peritoneal cavity (when, 
why and how?)
Rosana Troskot Perić
Department of Gastroenterology and Hepatology, University 
Hospital “Sveti Duh”, Zagreb, Croatia
Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, 
Croatia
Faculty of Health Studies, University of Rijeka, Rijeka, Croatia
Ascites is abnormal accumulation of fluid in the 
free abdominal (peritoneal) cavity. There are many 
causes of ascites, including cirrhosis of the liver, 
abdominal cancer, congestive heart failure, con-
strictive pericarditis, liver veno-occlusive disease, 
inflammatory causes, peritoneal dialysis, pancrea-
titis, abdominal trauma, and etc. The majority of 
patients presenting with a clinical manifestation of 
ascites have liver cirrhosis. Clinical manifestations 
of the ascites are distended (swelling) abdomen, 
abdominal discomfort and pain, dyspnoea, fever, 
shortness of breath, and etc. The gold standard for 
ascites diagnosis is ultrasound of the abdomen. If 
causes of ascites may not be determined based on 
the history, examination, and review of laboratory 
data and imaging studies it is necessary to do the 
paracentesis. It involves sterilizing of the area on 
the abdomen and, with the guidance of ultra-
sound, inserting a needle into the abdominal cavi-
ty and withdrawing fluid for further analysis. Ex-
cept for diagnostic purposes (to determine the 
cause of ascites), paracentesis is also performed in 
cases where a large amount of abdominal fluid 
significantly compromise breathing and in situa-
tions where the therapeutic response to diuretics 
is poor. Macroscopic appearance of ascites may in-
dicate the disease, e.g. “blurred” ascites indicates 
the development of secondary bacterial peritoni-
tis, “milky like” appearance is characteristic for chy-
lous ascites (triglycerides > 200 mg/dL), pink 
(haemorrhagic) appearance suggest a higher 
amounts of erythrocyte (> 10 000/mm3). Ascitic 
fluid analysis include: cell counts and differential 
for leukocytes (inflammatory sign); ascitic fluid to-
tal protein and albumin (to distinguish exudate 
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from transudates which is it clinically important 
because it is indicative of the underlying patho-
logical process), glucose, lactate dehydrogenase 
(LD), amylase, triglycerides, bilirubin, tumor mark-
ers (e.g. CEA, CA19-9, CA125) and others. The cyto-
logical examination of ascitic fluid is helpful in 
identifying and distinguishing the subgroups of 
malignancy-related ascites. Microbiological analy-
sis determines whether microorganisms are pre-
sent in fluids. 
Corresponding author: rtroskot@gmail.com
Synovial fluid - when, why and how?
Alan Ivković
Department of orthopaedic surgery, University hospital “Sveti 
Duh”, Zagreb, Croatia 
Joint aspiration and synovial fluid (SF) analysis is 
one the most commonly performed diagnostic 
procedures in modern clinical orthopaedics. Al-
though knee is the most common joint requiring 
aspiration, all non-axial joints are accessible for ob-
taining SF. The technique requires good knowl-
edge of anatomical landmarks and the use of ul-
trasound can be helpful in those smaller or/and 
less accessible joints. If performed under aseptic 
conditions and with sterile equipment the proce-
dure carries only minimal risk for the patient. Anal-
ysis of aspirated SF is very helpful in differential di-
agnosis of arthritis and provides definitive diagno-
sis in septic arthritis, crystalopathies and peripros-
thetic joint infections (PJI). Macroscopic appear-
ance of aspirate is very useful since it provides ini-
tial information and directs differential diagnosis. 
In general, the more inflammation is the present in 
the joint, the higher is volume of the aspirate, the 
higher is cell count and the higher is turbidity 
(muddiness of the liquid). Percentage of polymor-
phonuclear (PMN) leukocytes correlates well with 
degree of inflammation, and predominance of eo-
sinophils may be seen in parasitic infestations and 
other hypereosinophylic conditions. Number of 
leukocytes in aspirate is current golden standard 
in diagnosis of PJI, and the cut-of value is set at 
>2000 in mm3 for definitive diagnosis of PJI. Ap-
propriate stains and cultures, along with antibio-
gram should be performed in all SF samples. De-
tection of monosodium-urate (MSU) and calcium 
pyrophosphate dihydrate (CPPD) crystals is consid-
ered crucial in diagnosis of gout and pseudogout 
(calcium pyrophosphate dihydrate deposition dis-
ease), respectively. In conclusion, it is obvious that 
SF aspiration and analysis can be of major help in 
differential diagnosis of many joint pathologies. 
However, more research is warranted to further 
improve our understanding of the true value of SF 
inspection, cell counts, specificity and sensitivity 
of microbiological assays, crystal detection, bio-
chemical markers and cytological features.   
Corresponding author: alan.ivkovic@gmail.com
Verification of automated 
haematology analyser for 
body fluid analysis (guidelines, 
recommendations) 
Vanja Radisic Biljak
Department of Medical Laboratory Diagnostics; University 
Hospital “Sveti Duh”, Zagreb, Croatia 
The diagnostic value of the cellular components in 
body fluids has been evaluated in many inflamma-
tory diseases. Despite its many limitations, manual 
microscopy is still considered the gold standard 
for detecting and differentiating cells in body flu-
ids. However, development of the automated hae-
matology analysers has led to major improve-
ments in body fluid analysis for cellular composi-
tion. These analysers offer improved accuracy, pre-
cision and efficiency compared with manual mi-
croscopy methods. Considering the importance of 
cell enumeration in some clinical conditions (e.g. 
bacterial meningitis and cellular enumeration of 
cerebrospinal fluid), it is essential that the labora-
tory provide precise, accurate and reproducible re-
sults, thus imposing on laboratory professionals 
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some new challenges - how to properly and effi-
ciently perform the verification of automated cell 
counter for body fluids. The literature about this 
relevant topic is fairly scarce. The 2006 Clinical and 
Laboratory Standards Institute (CLSI) document 
H56-A Body Fluid Analysis for Cellular Composi-
tion; Approved Guideline provides recommenda-
tions for standardizing the collection and trans-
port of body fluids, numeration and identification 
of cellular components, and guidance for qualita-
tive and quantitative assessment of body fluid. 
Although the recommendations are clear and 
comprehensive, they lack some guidance for con-
ducting a proper verification of body fluid analysis 
on routine haematology analyser. In 2014 the In-
ternational Council for Standardization in Hema-
tology (ICSH) published the “Guidelines for the 
verification and performance of automated cell 
counters for body fluids” to assist laboratories to 
plan and execute the verification of their automat-
ed cell counters for automated body fluid counts. 
These guidelines represent valuable tool for every 
laboratory professional who has determined to 
cope with this demanding, yet challenging area of 
laboratory medicine. What is perhaps lacking are 
uniform, consistent and clearly defined quality re-
quirements. There is definitely room for a litera-
ture, as well as for a knowledge upgrade.
Corresponding author: vanja.radisic@gmail.com
Pre-analytical phase in analysis of 
pleural, peritoneal and synovial fluids
Dubravka Petro
Department of Medical Laboratory Diagnostics; University 
Hospital “Sveti Duh”, Zagreb, Croatia 
In aetiology of effusion, every formation of ex-
travascular fluid is a pathological process and sam-
ples are taken by punctuation of body cavities 
(punctates). Extravascular body fluid sample is 
generally considered irreplaceable because sam-
pling is often very invasive. Punctates are highly 
instable and therefore represent very challenging 
sample for laboratory analysis. Because of high 
content of fibrinogen, there is a quick formation of 
coagulum. Additionally, each temperature change 
is affecting the total count of blood cells and me-
tabolites (especially glucose). The most frequent 
laboratory analysis of body fluid samples include: 
haematological analysis (total white and red blood 
cells count), concentration of glucose, total pro-
teins and albumins, as well as determination of en-
zyme activity such as lactate dehydrogenase and 
amylase. The recommended tube for haematolo-
gy analysis is the EDTA anticoagulant test tube, 
while for biochemical analysis the recommended 
tube is heparin tube and heparin syringe for blood 
gas analysis. Common demand for each of these 
tests is the time of delivery no longer than 15 min-
utes after sampling in room temperature. Accord-
ing to our experience, the most common mistake 
in pre-analytic phase of body fluid testing is inad-
equate test tube with inadequate anticoagulant. 
In literature sample transport in inadequate tem-
perature is mentioned as the most common cause 
of mistake in pre-analytic phase of punctate analy-
sis. To ensure that body fluid sample is suitable for 
intended purpose there is a need for active dialog 
with people responsible for collecting samples 
and following the laboratory instructions for body 
fluid collection and transportation. 
The aim of this lecture is to give a review of the 
most common pre-analytical issues in analysis of 
pleural, peritoneal and synovial fluids, and possi-
bly provide some specific solutions.
Corresponding author: dubravka.petro@gmail.com
Urinary tract infections in the 
emergency department - diagnostic 
guidelines
Višnja Nesek Adam 
University Department for Anesthesiology, Resuscitation and 
Intensive Care, Emergency Medicine Department, Clinical 
Hospital “Sveti Duh”, Zagreb, Croatia 
Urinary tract infection (UTI) is a common clinical 
condition in the emergency department (ED) 
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which clinical presentations vary from the simple 
cystitis to urosepsis. Management of UTIs in the 
ED is very challenging due to high patient turno-
ver, limited history and lack of culture and suscep-
tibility test results. Because a urine culture is usu-
ally not available for 24–48 hours after an ED visit, 
diagnosis and treatment decisions are based on 
symptoms, physical findings, and some laboratory 
results. Although, diagnosis of UTI by clinical crite-
ria has very high diagnostic error rates of 30-50%, 
the use of diagnostic algorithms does not com-
pletely eliminate uncertainty. 
Urinalysis is valuable and the most frequently used 
diagnostic tool for the evaluation of potential uri-
nary tract infection, and accurate interpretation of 
urinalysis results is a key in diagnosis and proper 
antibiotics treatment. However, because urinalysis 
is so commonly ordered in the emergency depart-
ment, there is serious concern that misinterpreta-
tion may lead to overtreatment with antibiotics. 
Therefore, it is very important to understand both 
the strengths and the limitations of the diagnostic 
test for UTIs. Blood tests and further test beyond 
urinalysis and urine cultures are needed only to di-
agnose complicated UTI as well as for inpatients 
that develop UTIs. 
Corresponding author: visnja.nesek@hotmail.com 
Standardization of qualitative 
urinalysis in Croatia
Ana Dojder, Dora Vuljanić
Department of Medical Laboratory Diagnostics, University 
Hospital “Sveti Duh”, Zagreb, Croatia
Qualitative urinalysis is one of the most commonly 
used routine laboratory tests and is often a first 
step in the diagnostic pathway of urinary tract in-
fections, proteinuria, haematuria and some other 
conditions. Unfortunately, wide heterogeneity 
among dipstick manufacturers results in various 
dipsticks sensitivity, specificity and measurement 
range expressed as categories. 
In Croatia, 24 dipstick brands are available on the 
market and used interchangeably in 195 clinical 
laboratories. Comprehensive analytical verification 
showed that 12 most commonly used dipsticks are 
not sufficiently comparable. Besides low level of 
agreement, there is substantial variability in ana-
lytical performance. Consistent with previous 
studies, we verified that dipsticks do not accurate-
ly detect glucose and proteins regarding to quan-
titative measurements. Another analytical limita-
tion is unsatisfying precision for few parameters 
on the dipsticks, especially pH. 
The diversity of manufacturers is also manifested 
in the number of measurement fields for each pa-
rameter. Urine dipsticks have more strip pads than 
the number of categories recommended by the 
Croatian Chamber of Medical Biochemists (CCMB) 
for reporting results of dipsticks urinalysis. There-
fore, it is up to each laboratory to define concen-
tration ranges for all reporting categories. The re-
sults of questionnaire sent to 195 Croatian labora-
tories (response ratio was 71%) showed large in-
consistency in categories assigned to concentra-
tions. The fact that 30% false negative results were 
observed for leukocytes, and 21% for glucose, rep-
resents possible risk of unrecognized urinary tract 
infections and early diabetes.
Considering worldwide utilization of urine dip-
sticks, such heterogeneity and lack of standardiza-
tion may lead to diagnostic errors, patient misclas-
sification, and consequently jeopardize the patient 
safety. 
Corresponding author: ana.dojder@gmail.com
New biomarkers - an insight into the 
future 
Lora Dukić
Department of Medical Laboratory Diagnostics, University 
Hospital “Sveti Duh”, Zagreb, Croatia
One of the proposed definitions of the term “bio-
marker” describes it as “biological property whose 
in vitro measurement is useful for the prevention, 
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diagnosis, prognosis, treatment, and follow-up of 
diseases”. The Test Evaluation Working Group (TE-
WG) of the EFLM prepared set of interactive tools 
that enable evidence-based evaluation of novel 
biomarkers.  
Peritoneal fluid represents valuable matrix for de-
termination of biomarkers like adenosine deami-
nase (ADA) in differentiation between tuberculosis 
peritonitis and peritoneal carcinomatosis. Ascites 
is sort of “ecosystem” that modifies together with 
course of malignant disease, changing its cell con-
tent and “molecular signature”, thus giving valua-
ble information to the clinician. Use of microfluidic 
chip technology in ascites analysis facilitates moni-
toring of ovarian cancer treatment. 
Lipidomic analysis of synovial fluid (SF) from oste-
oarthritis and rheumatoid arthritis patients 
showed significant alteration in composition when 
compared to normal controls. Osteoarthritis sever-
ity could be estimated by detection of proportion 
of mesenchymal stem cells in synovial fluid. Detec-
tion techniques like GC/TOF MS enable compari-
son of metabolic profiling of SF in population of 
patients with rheumatoid arthritis and other in-
flammatory diseases. Recent studies on SF showed 
that S100A8/A9 and IL-35 could be used as diag-
nostic and prognostic biomarkers in RA.
Pleural fluid (PF) concentrations of IL-6, IL-8 and 
VEGF are increased in acute graft rejection of lung 
transplant. C-reactive protein, soluble triggering 
receptor expressed on myeloid cells (sTREM) and 
lipopolysaccharide-binding protein (LBP) in PF 
have discriminatory power in assessment of infec-
tious effusions. Beyond routinely used parameters 
in analysis of PF, there are publications pointing to 
biomarkers like ADA, cholesterol/triglyceride, in-
terferon-gamma, NT-proBNP, tumor markers, am-
ylase, creatinine, complement, antinuclear anti-
bodies and rheumatoid factor in detection of aeti-
ology of disorder. 
Novel promising biomarkers in analysis of urine 
are osteopontin, KIM-1, IL-18 and NGAL. 
Implementation of novel biomarkers into guide-
lines requires well-designed studies which follow 
defined checklists for evaluation of biomarkers.
Corresponding author: ldukic@kbsd.hr
